AVBP ArriVent BioPharma Inc.

Price (delayed)

$30.4

Market cap

$1.5B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.62

Enterprise value

$1.34B

?
Relative Growth: Rel. Growth: 5
Relative Strength: Rel. Strength: 79
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 5
Highlights
The equity has grown by 47% YoY and by 13% from the previous quarter
AVBP's debt is down by 16% since the previous quarter
The EPS has grown by 10% YoY but it has contracted by 4.3% from the previous quarter
The net income has declined by 20% year-on-year and by 13% since the previous quarter

Key stats

What are the main financial stats of AVBP

AVBP stock price

How has the ArriVent BioPharma stock price performed over time
Intraday
-0.36%
1 week
-1.94%
1 month
2.56%
1 year
58%
YTD
51.09%
QTD
-12.49%

Financial performance

How have ArriVent BioPharma's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$175.94M
Net income
-$163.74M
Gross margin
N/A
Net margin
N/A
The net income has declined by 20% year-on-year and by 13% since the previous quarter
ArriVent BioPharma's operating income has decreased by 19% YoY and by 12% from the previous quarter

Price vs fundamentals

How does AVBP's price correlate with its fundamentals

Growth

What is ArriVent BioPharma's growth rate over time

Valuation

What is ArriVent BioPharma stock price valuation
P/E
N/A
P/B
3.86
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 10% YoY but it has contracted by 4.3% from the previous quarter
The equity has grown by 47% YoY and by 13% from the previous quarter
AVBP's P/B is 21% above its last 4 quarters average of 3.2

Efficiency

How efficient is ArriVent BioPharma business performance
ArriVent BioPharma's ROIC has increased by 40% YoY but it has decreased by 3.7% from the previous quarter
ArriVent BioPharma's ROA has increased by 10% YoY but it has decreased by 2.9% from the previous quarter
ArriVent BioPharma's ROE has increased by 9% YoY but it has decreased by 2.7% from the previous quarter

Dividends

What is AVBP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AVBP.

Financial health

How did ArriVent BioPharma financials performed over time
ArriVent BioPharma's total assets has increased by 46% YoY and by 13% from the previous quarter
The company's total liabilities rose by 42% YoY and by 10% QoQ
AVBP's debt is 100% smaller than its equity
The equity has grown by 47% YoY and by 13% from the previous quarter
AVBP's debt is down by 16% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.